Cargando…
Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma
PURPOSE: Liver cancer stem cells (CSCs) are known to be associated with the development, survival, proliferation, metastasis, and recurrence of liver tumors. The aim of this study was to investigate the association of liver-enriched activator protein 1 (LAP1) with hepatocellular carcinoma (HCC) and...
Autores principales: | Yang, Li-Hua, Wang, Ye, Qiao, Shi, Wang, Min-Jun, Chen, Fei, Zi, Xiao-Yuan, Li, Jian-Xiu, Zhang, Hai-Bin, Yu, Bing, Hu, Yi-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927340/ https://www.ncbi.nlm.nih.gov/pubmed/29731667 http://dx.doi.org/10.2147/CMAR.S160172 |
Ejemplares similares
-
The CCAAT/Enhancer-Binding Protein Beta-2 Isoform (CEBPβ-2) Upregulates Galectin-7 Expression in Human Breast Cancer Cells
por: Campion, Carole G., et al.
Publicado: (2014) -
Role of the CCAAT-Binding Protein NFY in SCA17 Pathogenesis
por: Lee, Li-Ching, et al.
Publicado: (2012) -
Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas
por: Fang, Tao, et al.
Publicado: (2015) -
Sulforaphene Suppresses Adipocyte Differentiation via Induction of Post-Translational Degradation of CCAAT/Enhancer Binding Protein Beta (C/EBPβ)
por: Yang, Hee, et al.
Publicado: (2020) -
CCAAT/Enhancer-Binding Protein Homologous (CHOP) Protein Promotes Carcinogenesis in the DEN-Induced Hepatocellular Carcinoma Model
por: Scaiewicz, Viviana, et al.
Publicado: (2013)